ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 98 out of 1448

$450K Total Retail Price of All Prescriptions

Rank: 165 out of 1448

764 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

11 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 717 652 1 2
SIMVASTATIN 514 476 2 3
METOPROLOL SUCCINATE 491 451 3 6
LOSARTAN POTASSIUM 406 378 4 11
CARVEDILOL 346 314 5 1
FUROSEMIDE 324 286 6 7
DIOVAN 264 250 7 15
LISINOPRIL 228 198 8 5
HYDRALAZINE HCL 217 207 9 44
ATORVASTATIN CALCIUM 204 196 10 4
BENAZEPRIL HCL 203 184 11 26
WARFARIN SODIUM 193 174 12 8
AMLODIPINE BESYLATE-BENAZEPRIL 190 173 13 67
DIOVAN HCT 187 175 14 29
METFORMIN HCL 169 141 15 25
OMEPRAZOLE 160 157 16 23
LEVOTHYROXINE SODIUM 142 122 17 21
ATENOLOL 141 117 18 12
LOSARTAN-HYDROCHLOROTHIAZIDE 127 126 19 38
HYDROCHLOROTHIAZIDE 121 108 20 18
CLONIDINE HCL 111 102 21 45
NITROSTAT 109 101 22 31
CRESTOR 108 95 23 17
DIGOXIN 89 83 24 13
ISOSORBIDE MONONITRATE ER 82 81 25 16
AMIODARONE HCL 78 71 26 22
PANTOPRAZOLE SODIUM 77 67 27 42
PLAVIX 69 68 28 14
CLOPIDOGREL 66 66 29 10
LIPITOR 66 66 29 30
POTASSIUM CHLORIDE 65 52 31 19
NEXIUM 62 49 32 49
BYSTOLIC 58 57 33 32
PRAVASTATIN SODIUM 57 53 34 20
METOPROLOL TARTRATE 56 51 35 9
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 3, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.